Lab Report

Kam Primary Care PC

Reported By:	EmpireCity
Specimen:	2212202737
Requisition:	7970620
Collected Date:	12/20/2022 17:32:00
Received Date:	12/21/2022 01:09:00
Report Date:	12/21/2022 17:23:00
Report Status:	Final

Ordering Physician:	Kam, Yi Sheng
Patient Name:	PARKASH SHARMA, RATUL
DOB:	09/28/1993
AGE AS OF 12/25/2022:	29 Year
Gender:	Male
Phone:	2126519290
Patient ID:	7970620

CBC WITH DIFFERENTIAL (Status:Final)

Test Name	Abn	Result	Units	Range	Lab Code	Lab
WBC		5.1	10(3)/uL	4.0-11.0	38	ECL
RBC		4.7	10(6)/uL	4.3-5.7	39	ECL
HEMOGLOBIN		14.2	g/dL	13.5-17.5	40	ECL
HEMATOCRIT		41.0	%	39.0-50.0	41	ECL
MCV		87.0	fL	80-99	42	ECL
MCH		30	pg	25-33	43	ECL
MCHC		35	g/dL	31-35	44	ECL
RDWSD		39.4	fL	37.0-49.2	34-RDWSD	ECL
RDWCV		12.5	%	11.0-15.5	34-RDWCV	ECL
Platelet Count	Abnormal Low	112	10(3)/uL	150-450	34-PLT	ECL
MPV	Above High Normal	13.8	fL	9.7-13.0	49	ECL
Neutrophil Abs		3.05	10(3)/uL	1.40-6.51	34-NEUTAB	ECL
Lymphocyte Abs		1.49	10(3)/uL	0.57-3.97	34-LYMPAB	ECL
Monocyte Abs		0.48	10(3)/uL	0.22-0.93	34-MONOAB	ECL
Eosinophil Abs		0.03	10(3)/uL	0.00-0.39	34-EOSIAB	ECL
Basophil Abs		0.02	10(3)/uL	0.01-0.07	34-BASOAB	ECL
Immature Granulocyte Abs		0.01	10(3)/uL	0.00-0.10	34-IGAB	ECL
Neutrophil %		60.10	%	39.46-71.96	34-NEUTRE	ECL
Lymphocyte %		29	%	19-53	34-LYMPRE	ECL
Monocyte %		9.4	%	2.0-12.5	34-MONORE	ECL
Eosinophil %		0.6	%	0-7	34-EOSIRE	ECL
Basophil %		0.4	%	0-2	34-BASORE	ECL
Immature Granulocyte %		0.20	%	0.00-1.00	34-IGRE	ECL
NRBC %		0.0	%	0-0.1	34-NRBCS	ECL
NRBC Abs		0.00	10(3)/uL		34-NRBCAB	ECL

URINALYSIS COMPLETE (Status:Final)

Test Name	Abn	Result	Units	Range	Lab Code	Lab
GLUCOSE UA		NEGATIVE	mg/dL	NEGATIVE	7	ECL
BILIRUBIN		NEGATIVE		NEGATIVE	2	ECL
KETONES		NEGATIVE	mg/dL	NEGATIVE	4	ECL
SPECIFIC GRAVITY		1.034	SG units		9	ECL
BLOOD		NEGATIVE		NEGATIVE	1	ECL
PH		6.0	pH units	5.0-7.0	8	ECL
PROTEIN		NEGATIVE	mg/dL	NEGATIVE	5	ECL
UROBILINOGEN		NEGATIVE	mg/dl	NEGATIVE	3	ECL
NITRITE		NEGATIVE		NEGATIVE	6	ECL
LEUKOCYTE ESTERASE	Abnormal	SMALL		NEGATIVE	10	ECL
COLOR		YELLOW		YELLOW	11	ECL
TRANSPARENCY		CLEAR		CLEAR	12	ECL
RBC`S		0-2	RBC/HPF	0-2	39	ECL
WBC`S	Abnormal	6-10	WBC/HPF	0-5	38	ECL

CMP (COMPREHENSIVE METABOLIC PANEL) (Status:Final)

Test Name	Abn	Result	Units	Range	Lab Code	Lab
GLUCOSE NONFASTING,SERUM		92	mg/dL	65-134	79	ECL
SODIUM, SERUM		139	mEq/L	132-146	86	ECL
POTASSIUM, SERUM		4.6	mEq/L	3.5-5.5	83	ECL
CHLORIDE, SERUM		106	mEq/L	99-109	73	ECL
CARBON DIOXIDE		26	mEq/L	22-35	74	ECL
ANION GAP		11.6	mEq/L	7-18	4-001	ECL
BLOOD UREA NITROGEN	Above High Normal	26	mg/dL	9-23	69	ECL
CREATININE, SERUM		0.60	mg/dL	0.60-1.35	75	ECL
BUN/CREATININE RATIO	Above High Normal	43.33		6.0-22.0	366	ECL
CALCIUM, SERUM		9.6	mg/dL	8.3-10.6	70	ECL
TOTAL PROTEIN		7.5	g/dL	5.7-8.2	90	ECL
ALBUMIN		4.4	g/dL	3.2-5.1	64	ECL
GLOBULIN		3.1	gldl	1.8-4	4-GLOB	ECL
A/G RATIO		1.42	g/dl	1.00-2.10	99	ECL
BILIRUBIN, TOTAL		0.5	mg/dL	0.3-1.2	88	ECL
ALKALINE PHOSPHATASE, ALP		68	U/L	45-129	65	ECL
ALT (SGPT)		22	U/L	10-49	66	ECL
AST		26	U/L	17-34	68	ECL
EGFR NON AFR AMERICAN		169	mL/min/1.73m2	> or =60	372	ECL
EGFR AFR AMERICAN		205	mL/min/1.73m2	> or =60	2222	ECL

LIPID PANEL (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

CHOLESTEROL

131

mg/dL

< or =200

ECL

	Desirable Range < 200 mg/dL
	Borderline High Risk 200 to 239 mg/dL
	High risk > or = 240 mg/dL

LDL CALCULATION

68.2

mg/dL

0-130.00

ECL

	The American Heart Association recommends the following LDL cholesterol
	guidelines:
	Less than 100 mg/dL Optimal
	100 to 129 mg/dL Near Optimal/Above Optimal
	130 to 159 mg/dL Borderline High
	160 to 189 mg/dL High
	190 mg/dL and above Very High
	PLEASE NOTE:LDL calculation is only valid if the fasting triglyceride level is
	less than 400 mg/dl.

CHOL/HDL RATIO

2.57

ratio

0.00-7.00

ECL

HDL CHOLESTEROL

mg/dL

> or =40

ECL

	Low (high risk) < 40 mg/dL
	High (low risk) > or = 60 mg/dL

VLDL CALCULATION

11.8

mg/dl

5.0-40.0

512

ECL

TRIGLYCERIDES

mg/dL

< or =150

ECL

	Reference ranges:
	Normal: < 150 mg/dL
	Boderline high: 150 to 199 mg/dL
	Hypertriglyceridemia: 200 to 499 mg/dL
	High risk for pancreatitis : > or = 500 mg/dL

LIPEMIC

Slightly Lipemic

4-LIPE

ECL

HEPATITIS BS AG QUAL (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HEPATITIS BS AG SCREEN

NONREACTIVE

339

ECL

	Assay performance characteristics have not been established for immunocompromised
	or immunosuppressed patients, or infants. Heparin anticoagulants have been shown
	to reduce the Index values in some samples near the assay cut off. If acute or
	chronic HBV infection is suspected and the HBsAg result is nonreactive it is
	recommended that other HBV serological markers be tested to confirm the HBsAg
	nonreactivity.If acute or chronic HBV infection is suspected and the HBsAg result
	is nonreactive it is recommended that other HBV serological markers be tested to
	confirm the HBsAg nonreactivity.

HEPATITIS B CORE AB W/REF HEPATITIS B CORE(IGM) (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HEPATITIS B CORE AB QL

NONREACTIVE

579

ECL

	This test was performed using the ADVIA Centaur HBc Total assay. Values
	obtained with different assay methods, as determined by assays from different
	manufacturers, cannot be used interchangeably. Assay performance
	characteristics have not been established for immunocompromised,
	immunosuppressed, infants, children, or adolescent patients. A negative test
	result does not exclude the possibility of exposure to hepatitis B virus.
	Levels of anti-HBc may be undetectable both in early infection and late after
	infection. Results should be interpreted in conjunction with other diagnostic
	procedures, including information from the patients clinical evaluation.

HEPATITIS C AB QL (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HEPATITIS C AB QL

NONREACTIVE

343

ECL

	This test was performed using the ADVIA Centaur HCV assay. Values obtained with
	different assay methods, as determined by assays from different manufacturers,
	cannot be used interchangeably. Assay performance characteristics have not been
	established for immunocompromised, immunosuppressed, infants, children, or
	adolescent patients. Results should be interpreted in conjunction with other
	diagnostic procedures, including information from the patients clinical
	evaluation.

HIV 1,2 AG/AB, 4TH GENERATION (SCREEN) WITH REFLEXES (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HIV 1,2 AG/AB,4TH GENERATION

NONREACTIVE

5-CHIV

ECL

	This ADVIA Centaur HIV Ag/Ab Combo assay is an in vitro diagnostic immunoassay for the qualitative detection of human immunodeficiency virus (HIV) p24 antigen and antibodies to HIV types 1 and 2. It is intended to be used as an aid in the diagnosis of HIV infection in pediatric and adult populations, including pregnant women.
	A non-reactive test result does not exclude the possibility of infection with HIV as HIV antibodies and/or p24 antigen may be undetectable in some stages of the infection and in some clinical conditions. In patients less than 24 months of age, additional confirmatory testing is recommended.
	The above result is to be considered part of a confidential health record protected by state laws which prohibit making any further disclosure of this information without the specific written consent of the person to whom it pertains, or as otherwise permitted. A general authorization for the release of medical or other information is not sufficient authorization for further disclosure.

HERPES-1 IGG (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

Herpes-1 IGG

Negative

5-HSV1

ECL

	Effective 6/11/2020 the methodology for this test has been changed to
	Siemens Centaur XP.

HERPES-2 IGG (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

Herpes-2 IGG

Negative

5-hsv2

ECL

Effective 6/11/2020 the methodology for this test is changed to Siemens Centaur XP.

HEPATITIS BS AB (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HEPATITIS B SURFACE AB

Negative

5-aHBs2

ECL

	This test was performed using the ADVIA Centaur Anti-HBs2 assay. Values
	obtained with different assay methods, as determined by assays from different
	manufacturers, cannot be used interchangeably. Assay performance
	characteristics have not been established for immunocompromised or
	immunosuppressed patients, or in pregnant women. This assay does not
	differentiate between a vaccine-induced immune response and an immune response
	induced by infection with HBV. To determine if the anti-HBs response is due to
	vaccine or HBV infection, a total anti-HBc assay may be performed. Individuals
	who have received blood component therapies administered during the previous 36
	months may have a false reactive anti-HBs result due to passive transfer of
	anti-HBs.

GC/CHLAMYDIA (Status:Final)

	Test Name	Abn	Result	Units	Range	Lab Code	LOINC	Status	Lab
	CHLAMYDIA TRACHOMATIS		Negative		Not Detected	3-CT			ECL
	NEISSERIA GONORRHOEAE		Negative		Not Detected	3-NG			ECL

TRICHOMONAS VAGINALIS,DNA-PCR (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

TRICHOMONAS VAGINALIS

Negative

3-TRICHVAG

ECL

	This test was performed using the Cobas8800 Systems, an automated, qualitative in
	vitro nucleic acid diagnostic test, that utilizes real-time polymerase chain reaction
	(PCR), for the direct detection of Trichomonas Vaginalis (TV) in male and female
	urine. This test is intended as an aid in the diagnosis of trichomonas disease in
	both symptomatic and asymptomatic individuals.
	The Cobas 8800 TV/MG test enables the detection of TV/MG DNA in endocervical,
	vaginal, urine and cervical specimens of infected female patients and urine
	specimens in infected male patients. This test is FDA approved.

MYCOPLASMA GENITALIUM DNA - PCR (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

MYCOPLASMA GENITALIUM

Negative

3-MYCOGEN

ECL

	This test was performed using the Cobas8800 Systems, an automated, qualitative in
	vitro nucleic acid diagnostic test, that utilizes real-time polymerase chain reaction
	(PCR), for the direct detection of Mycoplasma Genitalium (MG) DNA in male and female
	urine. This test is intended as an aid in the diagnosis of mycoplasma genitalium
	disease in both symptomatic and asymptomatic individuals.
	The Cobas 8800 TV/MG test enables the detection of TV/MG DNA in endocervical,
	vaginal, urine and cervical specimens of infected female patients and urine specimens
	in infected male patients. This test is FDA approved.

Order Report (Status:Final)

	Test Name	Abn	Result	Units	Range	Lab Code	LOINC	Status	Lab
	PDFReport		Show Image	PDF	5577584	PDF			ECL

HEPATITIS A AB W/REF TO IGM (Status:Final)

Test Name

Abn

Result

Units

Range

Lab Code

LOINC

Status

Lab

HEPATITIS A TOTAL

Nonreactive

NONREACTIVE

43-AHAVU

ECL

Anti-HAV assay  performed on Liaison is an in vitro chemiluminescent immunoassay intended for the qualitative detection of total antibodies to Hepatitis A.

RAPID PLASMA REAGIN (Status:Final)

	Test Name	Abn	Result	Units	Range	Lab Code	LOINC	Status	Lab
	RPR W/RFX TITER		NonReactive		NONREACTIVE	151			ECL

Performing Laboratory Information:
ECL EMPIRE CITY LABORATORIES INC 229 49TH STREET BROOKLYN NY 112201708 Fermina M. Mazzella, MD

Reviewed by Yi Sheng . Kam , DO
Reviewed Date:12/22/2022

12/25/2022 6:27:50 PM printed by iClinic (MDLAND.com)